Exhibit 10.25 STOCK OPTION AGREEMENT NAME OF OPTIONEE: Philip Skolnick (the "Optionee") NO. OF OPTION SHARES: 250,000 Shares of Common Stock GRANT DATE: 1/19/01 (the "Grant Date") EXPIRATION DATE: 1/19/11 (the "Expiration Date") OPTION EXERCISE...Stock Option Agreement • April 5th, 2002 • Dov Pharmaceutical Inc • Pharmaceutical preparations • Delaware
ARTICLE 1 EMPLOYMENTEmployment Agreement • April 5th, 2002 • Dov Pharmaceutical Inc • Pharmaceutical preparations • New Jersey
Exhibit 10.2 PREFERRED STOCK PURCHASE AGREEMENTPreferred Stock Purchase Agreement • April 5th, 2002 • Dov Pharmaceutical Inc • Pharmaceutical preparations • New Jersey
Exhibit 10.15 Elan International Services, Ltd. c/o Elan Corporation, plc Flatts, Smiths Parish Bermuda, FL 04 Ladies and Gentlemen: Reference is made to the Securities Purchase Agreement ("SECURITIES PURCHASE AGREEMENT") dated as of January 21, 1999,...Securities Purchase Agreement • April 5th, 2002 • Dov Pharmaceutical Inc • Pharmaceutical preparations
Reference is made to the Securities Purchase Agreement ("SECURITIES PURCHASE AGREEMENT") dated as of January 21, 1999, by and between Elan International Services, Ltd ("EIS") and DOV Pharmaceutical, Inc. ("DOV"). This letter confirms and documents that EIS and its transferee affiliate Elan Pharmaceutical Investments, Ltd. hereby agree to the following: (1) EIS shall not exercise and hereby waives the Purchase Right, as defined in Section 6 of the Securities Purchase Agreement, to participate in the $7.07 million equity financing by DOV contemplated by the proposed enclosed form of purchase agreement with Biotechnology Value Fund, L.P., its affiliates and other investors, if any, that determine to participate (collectively, the ("INVESTORS") which is being carried out pursuant to the terms set forth in the attached form of preferred stock purchase agreement; (2) EIS hereby consents to the terms of the attached form of registration rights agreement among DOV and the Investors, which amon
Exhibit 10.27 January 23, 2002 Dr. Arnold Lippa Chief Executive Officer DOV Pharmaceutical, Inc. 433 Hackensack Avenue Hackensack NJ, 07601 RE: EXTENSION OF EMPLOYMENT AGREEMENT Dear Dr. Lippa: This will confirm the extension of your December 10,...Employment Agreement • April 5th, 2002 • Dov Pharmaceutical Inc • Pharmaceutical preparations
This will confirm the extension of your December 10, 1998, Employment Agreement with DOV Pharmaceutical, Inc. through December 10, 2004. All terms and conditions therein shall remain in full force and effect, except for the increase of your base compensation to $275,000 per year, and the increase of your car allowance to $1400 per month.
ARTICLE I EMPLOYMENTEmployment Agreement • April 5th, 2002 • Dov Pharmaceutical Inc • Pharmaceutical preparations • New Jersey
